in focus
From 1998 to 2018, LifeLink of Georgia's annual donor recoveries increased from 41 to 118.
From 1998 to 2018, LifeLink’s annual donor recoveries increased from 41 to 118.
Since developing its Multicultural Donation Education Program (MDEP) in 1994, LifeLink of Georgia has nearly tripled African-American donors.
While African Americans are 13.4 percent of the U.S. population*, they remain disproportionately represented on the current wait list (28.6 percent according to the most recent OPTN data).
African Americans are at increased risk for high blood pressure, diabetes and heart disease, all of which can lead to organ failure. They are also more likely to be highly sensitized, which can mean a compatible organ may take longer to receive.
Because compatible blood types and tissue markers are more likely to be found among members of the same ethnicity, increasing organ donation in minority groups is crucial to increasing transplants.
Through its focused quality improvement and education initiatives, LifeLink of Georgia has increased donor registration in the African-American communities across Georgia. This has led to a sustained increase in donor recoveries, and means more lifesaving organs can get to the patients who need them.
*According to the most recent U.S. Census Bureau population estimates.
Read about Bobby Howard, Director of Multicultural Donation Education at LifeLink, building trust in the community.
In focus
U.S. leads world in rates of deceased donors, key transplant categories
International data ranks U.S. highest in rates of deceased donors and kidney, liver and lung transplants.
HOPE Act impact continues at five-year milestone
More than 220 transplants have been performed to date through the HOPE Act.
LifeShare of Oklahoma increases DCD donor recovery during COVID-19
DCD recoveries are up across the country as OPOs build effective practices.
Using registries to improve outcomes and transplant management
UNOS builds and hosts registries enabling OPOs and transplant centers to address issues such as treatment, payment, quality improvement, benchmarking and clinical research.
